Mitochondrial disease in childhood: nuclear encoded

Neurotherapeutics. 2013 Apr;10(2):212-26. doi: 10.1007/s13311-013-0185-6.

Abstract

Primary mitochondrial disorders are clinically and genetically heterogeneous, caused by an alteration(s) in either mitochondrial DNA or nuclear DNA, and affect the respiratory chain's ability to undergo oxidative phosphorylation, leading to decreased production of adenosine triphosphophate and subsequent energy failure. These disorders may present at any age, but children tend to have an acute onset of disease compared with subacute or slowly progressive presentation in adults. Varying organ involvement also contributes to the phenotypic spectrum seen in these disorders. The childhood presentation of primary mitochondrial disease is mainly due to nuclear DNA mutations, with mitochondrial DNA mutations being less frequent in childhood and more prominent in adulthood disease. The clinician should be aware of the pediatric presentation of mitochondrial disease and have an understanding of the myriad of nuclear genes responsible for these disorders. The nuclear genes can be best understood by utilizing a classification system of location and function within the mitochondria.

Publication types

  • Review

MeSH terms

  • Cell Nucleus / genetics
  • Cell Nucleus / pathology*
  • Child
  • DNA, Mitochondrial / genetics
  • DNA, Mitochondrial / physiology
  • Gene Deletion
  • Genes
  • Humans
  • Mitochondrial Diseases / classification
  • Mitochondrial Diseases / genetics*
  • Mitochondrial Diseases / physiopathology
  • Mitochondrial Encephalomyopathies / genetics
  • Mitochondrial Encephalomyopathies / physiopathology
  • Nervous System Diseases / genetics
  • Nervous System Diseases / physiopathology

Substances

  • DNA, Mitochondrial